|
1
|
Buonaguro L, Petrizzo A, Tagliamonte M,
Tornesello ML and Buonaguro FM: Challenges in cancer vaccine
development for hepatocellular carcinoma. J Hepatol. 59:897–903.
2013.
|
|
2
|
El-Serag HB: Epidemiology of viral
hepatitis and hepatocellular carcinoma. Gastroenterology.
142:1264–1273.e1. 2012.
|
|
3
|
Shariff MI, Cox IJ, Gomaa AI, Khan SA,
Gedroyc W and Taylor-Robinson SD: Hepatocellular carcinoma: current
trends in worldwide epidemiology, risk factors, diagnosis and
therapeutics. Expet Rev Gastroenterol Hepatol. 3:353–367. 2009.
|
|
4
|
Chen XP, Qiu FZ, Wu ZD, Zhang ZW, Huang ZY
and Chen YF: Long-term outcome of resection of large hepatocellular
carcinoma. Brit J Surg. 93:600–606. 2006.
|
|
5
|
Johnson RL, Rothman AL, Xie J, et al:
Human homolog of patched, a candidate gene for the basal cell nevus
syndrome. Science. 272:1668–1671. 1996.
|
|
6
|
Wilkinson SE, Furic L, Buchanan G, et al:
Hedgehog signaling is active in human prostate cancer stroma and
regulates proliferation and differentiation of adjacent epithelium.
Prostate. 73:1810–1823. 2013.
|
|
7
|
Wang DH, Clemons NJ, Miyashita T, et al:
Aberrant epithelial-mesenchymal Hedgehog signaling characterizes
Barrett’s metaplasia. Gastroenterology. 138:1810–1822. 2010.
|
|
8
|
Huang S, He J, Zhang X, et al: Activation
of the hedgehog pathway in human hepatocellular carcinomas.
Carcinogenesis. 27:1334–1340. 2006.
|
|
9
|
Ruiz i Altaba A, Sánchez P and Dahmane N:
Gli and hedgehog in cancer: tumours, embryos and stem cells. Nat
Rev Cancer. 2:361–372. 2002.
|
|
10
|
Ingham PW and McMahon AP: Hedgehog
signaling in animal development: paradigms and principles. Genes
Dev. 15:3059–3087. 2001.
|
|
11
|
Cohen MM Jr: The hedgehog signaling
network. Am J Med Genet A. 123A:5–28. 2003.
|
|
12
|
Fiaschi M, Rozell B, Bergström A and
Toftgård R: Development of mammary tumors by conditional expression
of GLI1. Cancer Res. 69:4810–4817. 2009.
|
|
13
|
Stecca B and Ruiz i Altaba A: A GLI1-p53
inhibitory loop controls neural stem cell and tumour cell numbers.
EMBO J. 28:663–676. 2009.
|
|
14
|
Lo HW, Zhu H, Cao X, Aldrich A and
Ali-Osman F: A novel splice variant of GLI1 that promotes
glioblastoma cell migration and invasion. Cancer Res. 69:6790–6798.
2009.
|
|
15
|
Goel HL, Pursell B, Chang C, et al: GLI1
regulates a novel neuropilin-2/α6β1 integrin based autocrine
pathway that contributes to breast cancer initiation. EMBO Mol Med.
5:488–508. 2013.
|
|
16
|
Nolan-Stevaux O, Lau J, Truitt ML, et al:
GLI1 is regulated through Smoothened-independent mechanisms in
neoplastic pancreatic ducts and mediates PDAC cell survival and
transformation. Genes Dev. 23:24–36. 2009.
|
|
17
|
Patil MA, Zhang J, Ho C, Cheung ST, Fan ST
and Chen X: Hedgehog signaling in human hepatocellular carcinoma.
Cancer Biol Ther. 5:111–117. 2006.
|
|
18
|
Xu QR, Zheng X, Zan XF, Yao YM, Yang W and
Liu QG: Gli1 expression and its relationship with the expression of
Shh, Vimentin and E-cadherin in human hepatocellular carcinoma. Xi
Bao Yu Fen Zi Mian Yi Xue Za Zhi. 28:536–539. 2012.(In
Chinese).
|
|
19
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1956.
|
|
20
|
Christofk HR, Vander Heiden MG, Harris MH,
et al: The M2 splice isoform of pyruvate kinase is important for
cancer metabolism and tumour growth. Nature. 452:230–233. 2008.
|
|
21
|
Yang W, Xia Y, Hawke D, et al: PKM2
phosphorylates histone H3 and promotes gene transcription and
tumorigenesis. Cell. 150:685–696. 2012.
|
|
22
|
Gao X, Wang H, Yang JJ, Liu X and Liu ZR:
Pyruvate kinase M2 regulates gene transcription by acting as a
protein kinase. Mol Cell. 45:598–609. 2012.
|
|
23
|
Yang W and Lu Z: Regulation and function
of pyruvate kinase M2 in cancer. Cancer Lett. 339:153–158.
2013.
|
|
24
|
Hitosugi T, Kang S, Vander Heiden MG, et
al: Tyrosine phosphorylation inhibits PKM2 to promote the Warburg
effect and tumor growth. Sci Signal. 2:ra732009.
|
|
25
|
Kim JE, Chen J and Lou Z: DBC1 is a
negative regulator of SIRT1. Nature. 451:583–586. 2008.
|
|
26
|
Kim H, Chen J and Yu X: Ubiquitin-binding
protein RAP80 mediates BRCA1-dependent DNA damage response.
Science. 316:1202–1205. 2007.
|
|
27
|
Bolondi L, Sofia S, Siringo S, et al:
Surveillance programme of cirrhotic patients for early diagnosis
and treatment of hepatocellular carcinoma: a cost effectiveness
analysis. Gut. 48:251–259. 2001.
|
|
28
|
Oka H, Kurioka N, Kim K, et al:
Prospective study of early detection of hepatocellular carcinoma in
patients with cirrhosis. Hepatology. 12:680–687. 1990.
|
|
29
|
Zhang Y, Gong W, Dai S, et al:
Downregulation of human farnesoid X receptor by miR-421 promotes
proliferation and migration of hepatocellular carcinoma cells. Mol
Cancer Res. 10:516–522. 2012.
|
|
30
|
He Z, Wu J, Dang H, Lin H, Zheng H and
Zhong D: Polo-like kinase 1 contributes to the tumorigenicity of
BEL-7402 hepatoma cells via regulation of Survivin expression.
Cancer Lett. 303:92–98. 2011.
|
|
31
|
Yu Z, Peng S, PAN H-M and WANG K-F:
Expression of multi-drug resistance-related genes MDR3 and MRP as
prognostic factors in clinical liver cancer patients.
Hepatogastroenterology. 59:1556–1559. 2012.
|
|
32
|
Zhao Y, Altman BJ, Coloff JL, et al:
Glycogen synthase kinase 3alpha and 3beta mediate a
glucose-sensitive antiapoptotic signaling pathway to stabilize
Mcl-1. Mol Cell Biol. 27:4328–4339. 2007.
|
|
33
|
Kefas B, Comeau L, Erdle N, Montgomery E,
Amos S and Purow B: Pyruvate kinase M2 is a target of the
tumor-suppressive microRNA-326 and regulates the survival of glioma
cells. Neuro Oncol. 12:1102–1112. 2010.
|
|
34
|
Shi HS, Li D, Zhang J, et al: Silencing of
pkm2 increases the efficacy of docetaxel in human lung cancer
xenografts in mice. Cancer Sci. 101:1447–1453. 2010.
|
|
35
|
Yang W, Xia Y, Ji H, et al: Nuclear PKM2
regulates β-catenin transactivation upon EGFR activation. Nature.
480:118–122. 2011.
|
|
36
|
Briscoe J and Thérond PP: The mechanisms
of Hedgehog signalling and its roles in development and disease.
Nat Rev Mol Cell Biol. 14:416–429. 2013.
|
|
37
|
Zheng X, Yao Y, Xu Q, Tu K and Liu Q:
Evaluation of glioma-associated oncogene 1 expression and its
correlation with the expression of sonic hedgehog, E-cadherin and
S100a4 in human hepatocellular carcinoma. Mol Med Rep. 3:965–970.
2010.
|
|
38
|
Chen XL, Cheng QY, She MR, et al:
Expression of sonic hedgehog signaling components in hepatocellular
carcinoma and cyclopamine-induced apoptosis through Bcl-2
downregulation in vitro. Arch Med Res. 41:315–323. 2010.
|
